Morningstar Investment Management LLC Purchases 1,783 Shares of Kenvue Inc. $KVUE

Morningstar Investment Management LLC increased its position in Kenvue Inc. (NYSE:KVUE) by 16.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,571 shares of the company’s stock after purchasing an additional 1,783 shares during the period. Morningstar Investment Management LLC’s holdings in Kenvue were worth $263,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the company. Evergreen Wealth Solutions LLC boosted its stake in Kenvue by 2.6% in the 1st quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company’s stock worth $402,000 after purchasing an additional 432 shares in the last quarter. Scott & Selber Inc. boosted its stake in Kenvue by 0.4% in the 1st quarter. Scott & Selber Inc. now owns 106,621 shares of the company’s stock worth $2,557,000 after purchasing an additional 475 shares in the last quarter. Wealth Alliance LLC boosted its stake in Kenvue by 1.6% in the 1st quarter. Wealth Alliance LLC now owns 31,778 shares of the company’s stock worth $762,000 after purchasing an additional 486 shares in the last quarter. Everett Harris & Co. CA boosted its stake in Kenvue by 1.4% in the 1st quarter. Everett Harris & Co. CA now owns 36,971 shares of the company’s stock worth $887,000 after purchasing an additional 500 shares in the last quarter. Finally, Proffitt & Goodson Inc. boosted its stake in Kenvue by 8.2% in the 2nd quarter. Proffitt & Goodson Inc. now owns 6,831 shares of the company’s stock worth $143,000 after purchasing an additional 517 shares in the last quarter. Institutional investors own 97.64% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on KVUE shares. Evercore ISI decreased their target price on Kenvue from $23.00 to $18.00 and set an “in-line” rating for the company in a research report on Tuesday, September 23rd. Canaccord Genuity Group decreased their target price on Kenvue from $29.00 to $26.00 and set a “buy” rating for the company in a research report on Friday, August 8th. Rothschild Redb raised Kenvue from a “hold” rating to a “strong-buy” rating in a research report on Friday, September 26th. Barclays decreased their target price on Kenvue from $20.00 to $17.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Kenvue in a research report on Tuesday. One research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Kenvue presently has an average rating of “Hold” and an average target price of $21.18.

Kenvue Price Performance

NYSE KVUE opened at $16.18 on Wednesday. Kenvue Inc. has a 52 week low of $15.47 and a 52 week high of $25.17. The firm has a market capitalization of $31.04 billion, a P/E ratio of 21.86, a PEG ratio of 2.33 and a beta of 0.72. The company has a quick ratio of 0.68, a current ratio of 0.98 and a debt-to-equity ratio of 0.66. The company has a 50-day moving average price of $18.92 and a 200-day moving average price of $21.22.

Kenvue (NYSE:KVUE) last announced its quarterly earnings data on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.28 by $0.01. The company had revenue of $3.84 billion during the quarter, compared to the consensus estimate of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.The firm’s revenue was down 4.0% on a year-over-year basis. During the same period in the previous year, the company posted $0.32 EPS. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. Equities research analysts anticipate that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 27th. Investors of record on Wednesday, August 13th were paid a dividend of $0.2075 per share. This is a boost from Kenvue’s previous quarterly dividend of $0.21. The ex-dividend date was Wednesday, August 13th. This represents a $0.83 dividend on an annualized basis and a dividend yield of 5.1%. Kenvue’s dividend payout ratio is presently 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.